On February 15, 2024, dsm-firmenich announced the initiation of a process to carve out and separate the Animal Nutrition & Health ("ANH") business from the company.
According to a release, ANH is driven by different dynamics from the rest of dsm-firmenich, which has become even more apparent with the unprecedented challenges in the vitamins market. dsm-firmenich believes that the full potential of the ANH business could be best realized through a different ownership structure for which all potential separation options will be considered. The company would expect to be in a position to separate the business in 2025.
Dimitri de Vreeze, CEO of dsm-firmenich, commented, "Our purpose at dsm-firmenich is to bring Progress to Life, as we boost innovation in premium, high-growth and resilient segments. ANH is a fantastic business that over the years we have built to be a true leader in the industry. This is a difficult moment, but we strongly believe that a separation would be better for both businesses and their employees, and ultimately generate better value for all our stakeholders."
The perimeter of the ANH business expected to be separated is being reviewed as part of this process. Ivo Lansbergen will continue to lead the ANH business. He joined in 1997 and led ANH since 2019.
Lansbergen, president, Animal Nutrition & Health, commented, "We have an amazing team within ANH that has built a global leader with scale, a unique portfolio and unrivalled innovation capabilities to help our customers tackle some of the most challenging food security issues and with a strategy that is strongly focused on Making Animal Farming Sustainable. It is an exciting prospect for our world class team to pursue our ANH strategy."
During the process, dsm-firmenich has declared that it "remains committed to the ANH business, its market-leading team and to providing excellent service to customers as the business transitions to a new ownership structure to deliver its full potential."
